Guardant Health Announced Preliminary FY2024 Sales Of Approximately $737M, An Increase Of 31% Compared To Consensus Of $723.9M

Benzinga20:09

Express News | Guardant Health Q4 Revenue USD 200 Million Vs. IBES Estimate USD 186.7 Million

Breakings20:00

Press Release: Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results

Dow Jones20:00

Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?

BenzingaJan 12 22:47

UBS Maintains Guardant Health(GH.US) With Buy Rating, Maintains Target Price $40

Futu NewsJan 11 06:31 · Ratings

Guardant Health Holds 'Underappreciated' Catalyst Path, UBS Says

MT NewswiresJan 11 04:12